Acumen Total Assets from 2010 to 2026
| ABOS Stock | USD 2.51 0.12 5.02% |
Total Assets | First Reported 2020-12-31 | Previous Quarter 171.9 M | Current Value 142.2 M | Quarterly Volatility 78.2 M |
Check Acumen Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acumen Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 12.4 M, Interest Income of 17.3 M or Depreciation And Amortization of 152.2 K, as well as many indicators such as Price To Sales Ratio of 296, Dividend Yield of 0.0 or PTB Ratio of 0.54. Acumen financial statements analysis is a perfect complement when working with Acumen Pharmaceuticals Valuation or Volatility modules.
Acumen | Total Assets | Build AI portfolio with Acumen Stock |
The evolution of Total Assets for Acumen Pharmaceuticals provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Acumen Pharmaceuticals compares to historical norms and industry peers.
Latest Acumen Pharmaceuticals' Total Assets Growth Pattern
Below is the plot of the Total Assets of Acumen Pharmaceuticals over the last few years. Total assets refers to the total amount of Acumen Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Acumen Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Acumen Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Acumen Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 238.99 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Acumen Total Assets Regression Statistics
| Arithmetic Mean | 91,585,356 | |
| Geometric Mean | 27,744,526 | |
| Coefficient Of Variation | 126.85 | |
| Mean Deviation | 104,681,166 | |
| Median | 7,322,000 | |
| Standard Deviation | 116,176,450 | |
| Sample Variance | 13497T | |
| Range | 302.8M | |
| R-Value | 0.82 | |
| Mean Square Error | 4643.8T | |
| R-Squared | 0.68 | |
| Significance | 0.000049 | |
| Slope | 18,935,800 | |
| Total Sum of Squares | 215951.5T |
Acumen Total Assets History
Other Fundumenentals of Acumen Pharmaceuticals
Acumen Pharmaceuticals Total Assets component correlations
Click cells to compare fundamentals
About Acumen Pharmaceuticals Financial Statements
Acumen Pharmaceuticals shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Acumen Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Acumen Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Acumen Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 274.8 M | 188.4 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.